JP2004520041A5 - - Google Patents

Download PDF

Info

Publication number
JP2004520041A5
JP2004520041A5 JP2002558535A JP2002558535A JP2004520041A5 JP 2004520041 A5 JP2004520041 A5 JP 2004520041A5 JP 2002558535 A JP2002558535 A JP 2002558535A JP 2002558535 A JP2002558535 A JP 2002558535A JP 2004520041 A5 JP2004520041 A5 JP 2004520041A5
Authority
JP
Japan
Prior art keywords
bace
polypeptide
nogo
modulator
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002558535A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004520041A (ja
Filing date
Publication date
Priority claimed from GBGB0101312.7A external-priority patent/GB0101312D0/en
Application filed filed Critical
Publication of JP2004520041A publication Critical patent/JP2004520041A/ja
Publication of JP2004520041A5 publication Critical patent/JP2004520041A5/ja
Pending legal-status Critical Current

Links

JP2002558535A 2001-01-18 2002-01-18 新規アッセイ Pending JP2004520041A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0101312.7A GB0101312D0 (en) 2001-01-18 2001-01-18 Assay
PCT/GB2002/000228 WO2002057483A2 (en) 2001-01-18 2002-01-18 Method of identifying modulators of nogo-functions

Publications (2)

Publication Number Publication Date
JP2004520041A JP2004520041A (ja) 2004-07-08
JP2004520041A5 true JP2004520041A5 (https=) 2005-12-22

Family

ID=9907052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002558535A Pending JP2004520041A (ja) 2001-01-18 2002-01-18 新規アッセイ

Country Status (6)

Country Link
US (2) US7270962B2 (https=)
EP (1) EP1390758A2 (https=)
JP (1) JP2004520041A (https=)
AU (1) AU2002225174A1 (https=)
GB (1) GB0101312D0 (https=)
WO (1) WO2002057483A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011130347A2 (en) * 2010-04-13 2011-10-20 The Johns Hopkins University Methods for enhancing axonal regeneration
CN119768424A (zh) * 2022-08-22 2025-04-04 舒泰神(北京)生物制药股份有限公司 特异性识别Nogo-A的抗体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ304224B6 (cs) * 1998-11-06 2014-01-15 Schwab Monoklonální protilátka
US7087399B1 (en) * 1999-05-13 2006-08-08 Scios, Inc. β-secretase and modulation of β-secretase activity
IL150566A0 (en) 2000-01-12 2003-02-12 Univ Yale Nucleic acids and polypeptides and nogo-receptor proteins
GB0101313D0 (en) 2001-01-18 2001-02-28 Glaxo Group Ltd Assay

Similar Documents

Publication Publication Date Title
Fan et al. Research progress of vagus nerve stimulation in the treatment of epilepsy
Carlson et al. Conditional overexpression of insulin-like growth factor-1 enhances hippocampal neurogenesis and restores immature neuron dendritic processes after traumatic brain injury
WO2008105797A3 (en) Polynucleotides encoding novel pcsk9 variants
BRPI0410296A (pt) sistema e método para a determinação da eficácia de tratamento de distúrbios neurológicos utilizando o eletroencefalograma
Shabir et al. Assessment of neurovascular coupling and cortical spreading depression in mixed mouse models of atherosclerosis and Alzheimer’s disease
Duricki et al. Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke
Tinazzi et al. Deficits of temporal discrimination in dystonia are independent from the spatial distance between the loci of tactile stimulation
NZ592516A (en) Antibodies to il-6 and use thereof
IS8432A (is) Mótefni sem bindast viðtaka hvítfrumuboða-4
Lindemann et al. Vagus nerve stimulation reduces spreading depolarization burden and cortical infarct volume in a rat model of stroke
IL178121A0 (en) Therapeutic use of anti-cs1 antibodies
CR10627A (es) Metodos terapeuticos para el tratamiento de trastornos oculares vasculares con antagonistas de dii4
WO2008011083A3 (en) Compounds for enhancing arginase activity and methods of use thereof
RU2016151179A (ru) Ornithodoros moubata игибитор комплемента, предназначенный для лечения опосредованных комплементом заболеваний пациента с полиморфизмом с5 комплемента
JP2004520041A5 (https=)
WO2006112951A3 (en) Method of risk management for patients undergoing natalizumab treatment
JP2009505979A5 (https=)
WO2004100886A3 (en) POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-kB PATHWAY
BR0314713A (pt) Processos e reagentes para o tratamento de doenças e distúrbios associados com nìveis aumentados de citocinas pró-inflamatórias
JP2004531697A5 (https=)
Khetarpal et al. Comparison of spinal anesthesia and paravertebral block in inguinal hernia repair
JP2020007333A5 (https=)
ATE490979T1 (de) Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene
Mauguiere et al. HM never again! An analysis of HM’s epilepsy and treatment
EP1363528A4 (en) METHODS OF DIAGNOSING AND TREATING CARDIOPATHIES